(Q46912071)

26 December 2017

title

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome (English)

1 reference

26 December 2017

1 reference

10

Lutz Weber

1 reference

26 December 2017

author name string

Markus J Kemper

1

1 reference

26 December 2017

Jutta Gellermann

2

1 reference

26 December 2017

Sandra Habbig

3

1 reference

26 December 2017

Rafael T Krmar

4

1 reference

26 December 2017

Katalin Dittrich

5

1 reference

26 December 2017

Therese Jungraithmayr

6

1 reference

26 December 2017

Lars Pape

7

1 reference

26 December 2017

Ludwig Patzer

8

1 reference

26 December 2017

Heiko Billing

9

1 reference

26 December 2017

Martin Pohl

11

1 reference

26 December 2017

Katrin Rosenthal

12

1 reference

26 December 2017

Anne Rosahl

13

1 reference

26 December 2017

Dirk E Mueller-Wiefel

14

1 reference

26 December 2017

Jörg Dötsch

15

1 reference

26 December 2017

language of work or name

English

0 references

publication date

9 November 2011

1 reference

26 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

1910-1915

1 reference

26 December 2017

Management of childhood onset nephrotic syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Rituximab in refractory nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Fatal pulmonary fibrosis after rituximab administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

Rituximab: mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR548

21 January 2018

Identifiers

DOI

10.1093/NDT/GFR548

1 reference

26 December 2017

1 reference

26 December 2017